Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kallikreins are a subgroup of serine proteases involved in various physiological processes including blood pressure regulation, inflammation, and semen liquefaction. They are synthesized as inactive pro-proteins and activated by proteolytic cleavage. Dysregulation of kallikreins has been implicated in cancer, cardiovascular disorders, and inflammatory conditions, making them potential therapeutic targets and biomarkers.
Kallikreins are serine proteases that cleave peptide bonds in proteins, particularly kininogens, to release kinins like bradykinin, which mediates vasodilation and inflammation. They also play roles in semen liquefaction and extracellular matrix remodeling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kallikrein (KLK).